You are here

Industry News

Advamed Smart Brief

May 22, 2018
An oversubscribed Series C funding round that included Chinese investors raised $300 million for Grail, a developer of blood- -More
May 22, 2018
An initial public offering was filed with the SEC by Basking Ridge, N.J.-based electroCore in hopes of raising up to $75 mill -More
May 22, 2018
An exclusive distribution agreement was reached by Valeritas and Med Trust for the commercialization of Valeritas' V-Go insul -More
May 22, 2018
Ankit Shah was tapped to serve as senior director of commercialization and marketing at SetPoint Medical.  -More
May 22, 2018
Isabelle Raymond, former director of scientific and professional affairs at Exeltis, was named vice president of clinical dev -More
May 22, 2018
Minnesota has the institutions and the talent to transform health care in the US.  -More
May 22, 2018
Motus GI secured a patent from the Chinese Patent Office for its Pure-Vu System, which is designed for cleansing the colon to -More
May 22, 2018
The second Connected Health Innovation Award was launched by Zimmer Biomet in the Europe, Middle East and Africa region to di -More
May 22, 2018
The FDA granted Johnson & Johnson subsidiary Cerenovus 510(k) clearance for its Embotrap II Revascularization Device, a next- -More
May 22, 2018
The FDA gave Xtant Medical clearance to market its InTice-C Porous Titanium Cervical Interbody System, which is intended for  -More

Industry News

Helius Medical Technologies, Inc.
NEWTOWN, PA.,  April 11, 2018 - Helius Medical Technologies, Inc. (“Helius” or the “Company”) today announced the pricing of an underwritten public offering of 2,141,900 shares of its Class A common stock and warrants to purchase 2,141,900 shares of its Class A common stock at a public offering price of US$7.47 per share and accompanying warrant, before underwriting discounts and commissions.  The net proceeds to the Company from this offering, after deducting the underwriting discounts,...
PR Newswire
California-based Myoscience, Inc. announced today that it received 510k clearance from the US FDA for Smart Tip with Nerve Stim, the latest innovative tip for Myoscience’s iovera° platform technology. With the FDA clearance for Smart Tip with Nerve Stim, physicians will be able to stimulate a nerve in advance of delivering iovera° cold therapy to the treatment area, reducing patient treatment times. Additionally, the use of Smart Tip with Nerve Stim enables physicians using iovera° to access...
Media Planet
It sometimes strikes without warning. People of any age, race, ethnicity and gender are at risk. In fact, it is the leading killer of both men and women in America. It is heart disease, and each year it claims the lives of over 600,000 Americans, accounting for one-quarter of all deaths in the United States. 
Boston Scientific
Boston Scientific commends the efforts of key champions in the U.S. House and Senate for their successful efforts to suspend the medical device tax, allowing the device industry to reinvest in work to benefit patients.
Sysmex America
LINCOLNSHIRE, ILL. – Nov. 8, 2017 – Sysmex America announced today that its Sysmex XW-100 received clearance from the U.S. Food and Drug Administration (FDA)—making it the first Clinical Laboratory Improvement Amendments (CLIA)-waived, complete blood count (CBC) system. Once prepared for each day’s use, the XW-100 will allow health care professionals to provide patients with blood test results in as few as three minutes.